Skip to main content
Top
Published in: Supportive Care in Cancer 9/2014

01-09-2014 | Original Article

Are orange lollies effective in preventing nausea and vomiting related to dimethyl sulfoxide? A multicenter randomized trial

Authors: Silvia Gonella, Paola Berchialla, Benedetto Bruno, Paola Di Giulio

Published in: Supportive Care in Cancer | Issue 9/2014

Login to get access

Abstract

Purpose

Nausea and vomiting (NV) related to DMSO affect patients undergoing auto-SCT despite antiemetic measures. Orange flavoring may reduce gastrointestinal symptoms.

Methods

A multicenter, randomized, three-arm, open-label trial in four Italian large bone marrow transplant centers was conducted to assess the effectiveness of orange aroma in preventing NV related to DMSO. Patients were randomized to orange ice lollies, non-citrus ice lollies, and routine treatment (deep breaths) during reinfusion. Data on NV were collected up to 5 days after infusion; 69/98 patients were randomized: 23 to orange, 21 to non-citrus ice lollies, and 25 to routine treatment.

Results

Although 48 h after transplantation no differences were observed in controlled nausea (Numerical Rating Scale (NRS) 0–100, ≤25) or vomiting, significantly fewer patients had no episodes of vomiting, no antiemetic rescue therapy, and no nausea (NRS <5) in the deep breath vs lollies groups (P = 0.017). The intensity of nausea over time differed significantly between ice lollies vs routine care (P = 0.001) groups, but not between the orange and non-citrus groups (P = 0.428).

Conclusion

The vasoconstrictive action of ice may prevent NV related to DMSO in the acute phase and reduce the need for rescue antiemetic therapy. Ice lollies offer a simple, noninvasive, and economic means for relieving nausea and vomiting related to this preservative.
Literature
4.
go back to reference Horacek JM, Jebavy L, Jakl M, Zak P, Mericka P, Maly J (2009) Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients—impact of cryopreservation with dimethylsulfoxide. Exp Oncol 31:121–122PubMed Horacek JM, Jebavy L, Jakl M, Zak P, Mericka P, Maly J (2009) Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients—impact of cryopreservation with dimethylsulfoxide. Exp Oncol 31:121–122PubMed
5.
go back to reference Prior D, Mitchell A, Nebauer M, Smith M (2000) Oncology nurses’ experience of dimethyl sulfoxide odor. Cancer Nurs 23:134–140PubMedCrossRef Prior D, Mitchell A, Nebauer M, Smith M (2000) Oncology nurses’ experience of dimethyl sulfoxide odor. Cancer Nurs 23:134–140PubMedCrossRef
7.
go back to reference Cox MA, Kastrup J, Hrubisko M (2012) Historical perspectives and the future of adverse reactions associated with haemopoietic stem cell cryopreserved with dimethyl sulfoxide. Cell Tissue Bank 13:203–215. doi:10.1007/s10561-011-9248-2 PubMedCrossRef Cox MA, Kastrup J, Hrubisko M (2012) Historical perspectives and the future of adverse reactions associated with haemopoietic stem cell cryopreserved with dimethyl sulfoxide. Cell Tissue Bank 13:203–215. doi:10.​1007/​s10561-011-9248-2 PubMedCrossRef
11.
go back to reference Ndao DH, Ladas EJ, Cheng B, Sands SA, Snyder KT, Garvin JH Jr et al (2012) Inhalation aromatherapy in children and adolescents undergoing stem cell infusion: results of a placebo-controlled double-blind trial. Psycho-Oncology 21:247–254. doi:10.1002/pon.1898 PubMedCrossRef Ndao DH, Ladas EJ, Cheng B, Sands SA, Snyder KT, Garvin JH Jr et al (2012) Inhalation aromatherapy in children and adolescents undergoing stem cell infusion: results of a placebo-controlled double-blind trial. Psycho-Oncology 21:247–254. doi:10.​1002/​pon.​1898 PubMedCrossRef
12.
go back to reference Lopez-Jiménez J, Martin-Ballesteros E, Sureda A, Uralburo C, Lorenzo I, Del Campo R et al (2006) Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: result of a multi-center observational study. Haematologica 91:84–91PubMed Lopez-Jiménez J, Martin-Ballesteros E, Sureda A, Uralburo C, Lorenzo I, Del Campo R et al (2006) Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: result of a multi-center observational study. Haematologica 91:84–91PubMed
15.
go back to reference Aungst JL, Heyward PM, Puche AC, Karnup SV, Hayar A, Szabo G et al (2003) Centre-surround inhibition among olfactory bulb glomeruli. Nature 426:623–629. doi:10.1038/nature02185 Aungst JL, Heyward PM, Puche AC, Karnup SV, Hayar A, Szabo G et al (2003) Centre-surround inhibition among olfactory bulb glomeruli. Nature 426:623–629. doi:10.​1038/​nature02185
20.
go back to reference Hesketh PJ (1999) Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice. Oncologist 4:191–196PubMed Hesketh PJ (1999) Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice. Oncologist 4:191–196PubMed
21.
go back to reference Harrell FE (2001) Regression modeling strategies with applications to linear model, logistic regression and survival analysis. Springer, New York Harrell FE (2001) Regression modeling strategies with applications to linear model, logistic regression and survival analysis. Springer, New York
24.
go back to reference Sonis S, Elting L, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology and consequences for patients. Cancer 100(Suppl 9):1995–2025. doi:10.1002/cncr.20162 PubMedCrossRef Sonis S, Elting L, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology and consequences for patients. Cancer 100(Suppl 9):1995–2025. doi:10.​1002/​cncr.​20162 PubMedCrossRef
25.
go back to reference Vokurka S, Bystricka E, Koza V, Scudlova J, Pavlicova V, Valentova D et al (2006) Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study. Support Care Cancer 14:974–976. doi:10.1007/s00520-006-0031-z PubMedCrossRef Vokurka S, Bystricka E, Koza V, Scudlova J, Pavlicova V, Valentova D et al (2006) Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study. Support Care Cancer 14:974–976. doi:10.​1007/​s00520-006-0031-z PubMedCrossRef
26.
go back to reference Grazziutti ML, Dong L, Miceli MH, Krishna SG, Kiwan E, Syed N et al (2006) Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow Transplant 38:501–506. doi:10.1038/sj.bmt.1705471 PubMedCrossRef Grazziutti ML, Dong L, Miceli MH, Krishna SG, Kiwan E, Syed N et al (2006) Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow Transplant 38:501–506. doi:10.​1038/​sj.​bmt.​1705471 PubMedCrossRef
27.
go back to reference Costa LJ, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Litzow MR et al (2008) Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma. BJH 143:268–273. doi:10.1111/j.1365-2141.2008.07342.x PubMedCrossRef Costa LJ, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Litzow MR et al (2008) Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma. BJH 143:268–273. doi:10.​1111/​j.​1365-2141.​2008.​07342.​x PubMedCrossRef
Metadata
Title
Are orange lollies effective in preventing nausea and vomiting related to dimethyl sulfoxide? A multicenter randomized trial
Authors
Silvia Gonella
Paola Berchialla
Benedetto Bruno
Paola Di Giulio
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 9/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2227-y

Other articles of this Issue 9/2014

Supportive Care in Cancer 9/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine